Click on the plus icons to view more information about each section.
R&D expertise combined with a lean operating model
Semi-virtual model using in-house specialist expertise in Clinical Development, Regulatory and Chemistry, Manufacturing and Controls (CMC) to lead strategy and co-ordinate the outsourcing of key activities with a range of experienced consultants and highly regarded subcontractors.
Proven innovation
Expertise in optimising formulations of molecules and excipients to ensure a rapid and targeted action and to minimise side effects.
Understanding our markets
Our lead asset MED3000, as well as the rest of our pipeline assets, are well positioned to meet the demands behind the current market dynamics driving chronic disease such as obesity, stress and anxiety which, combined with increasing prosperity and expectations from patients and consumers for a high quality of life, lead to increased demand. Not only are people living longer but they want to live an active, pain-free and fulfilled lifestyle for longer. Products such as MED3000 are well placed to accommodate such demands.
Understanding patient and consumer needs
In sexual health, current treatments do not meet the needs of many men with erectile dysfunction who are looking for a fast-acting and well tolerated treatment that can help restore spontaneity and intimacy back into their relationship. ED can also contribute to low confidence and self-esteem and have a significant impact on the mental health of the sufferer as well as their partner’s.